Collaborative Cancer Grand Rounds

Please contact Melynda Noble ( for Zoom info, RSVP HERE to attend in person

Outcome Objectives:

Nathan Cherrington, PhD
Presentation: Diagnosing NASH through Direct Measurement of Hepatic ADME Impairment

  • Understand how interindividual variability in ADME alters pharmacologic response
  • Understand the mechanisms for how NASH alters the pharmacokinetics of specific drugs
  • See novel approaches being developed to diagnose patients with hepatic impairment

Xinxin Ding, PhD
Presentation: Mechanisms of Environmental Chemical Induced Lung Carcinogenesis

  • General understanding of modes of action of chemical carcinogens
  • Knowledge of metabolic fates of environmental chemicals in the body
  • Knowledge of specific carcinogens in environmental mixtures
  • Knowledge of research approaches that utilize knockout mouse models

Accreditation Statement:
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement(s):
All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.


Noon to 1 p.m. Oct. 22, 2021


Kiewit Auditorium, University of Arizona Cancer Center

Event Contacts